Tracking daprodustat for kidney disease anemia
Part of Blood & lymphatic, Kidney & urinary clinical trials.
This study is collecting information from people with chronic kidney disease and anemia who are taking a medication called daprodustat. The goal is to learn more about how well it works and how it affects patients in real life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have chronic kidney disease (CKD) with anemia (low red blood cells).
- Your kidney function is reduced (CKD stages 3-5), you are on dialysis, or you have had a kidney transplant.
- You are starting or currently taking daprodustat, a medication to treat anemia.
- You are willing to participate and provide consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two anemia medicines for people with chronic kidney disease (CKD) who are not on dialysis. It aims to find a more convenient pill option (daprodustat) versus a commonly used injection (epoetin alfa).
This study tests an experimental medicine for anemia in people with kidney disease who are on dialysis. It aims to see if it can help raise blood counts safely compared to standard treatments.
This study tests whether a pill called roxadustat can help improve kidney oxygen levels in people with diabetes-related kidney disease and anemia. It may help boost your red blood cells and improve how your kidneys work.
This trial tests enarodustat, a pill for anemia, in people with chronic kidney disease who are not on dialysis. It aims to see if it can safely raise hemoglobin levels.
This study tracks the real-world safety of desidustat in adults with anemia caused by chronic kidney disease (CKD). It’s meant to see whether the medicine is safe when used in everyday care, not just in tightly controlled settings.
This study looks at whether a drug called roxadustat helps people who have heart failure, anemia, and moderate-to-severe chronic kidney disease. The trial focuses on people who have already been taking roxadustat for more than a year.
Hear when a new CKD Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.